[Federal Register Volume 64, Number 238 (Monday, December 13, 1999)]
[Notices]
[Pages 69538-69539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-32165]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Care Financing Administration
[HCFA-3029-N]
Medicare Program; Meeting of the Medical and Surgical Procedures
Panel of the Medicare Coverage Advisory Committee--January 19 and 20,
2000
AGENCY: Health Care Financing Administration (HCFA), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting of the Medical and
Surgical Procedures Panel of the Medicare Coverage Advisory Committee
(MCAC). The panel provides advice and recommendations to the agency
about clinical coverage issues. The panel will hear and discuss
presentations from interested persons regarding behavioral
interventions (pelvic muscle rehabilitation) for the management of non-
neurogenic urinary incontinence in adults. The meeting will primarily
focus on two management options: biofeedback and pelvic floor
electrical stimulation. Notice of this meeting is given under the
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)).
DATES:
The Meeting: The meeting will be held on January 19, 2000 from 8:30
a.m. until 5 p.m., E.D.T., and on January 20, 2000, from 8:30 a.m.
until 3:00 p.m., E.D.T.
[[Page 69539]]
Deadline for Presentations and Comments: You must submit formal
presentations and written comments to the For Further Information
Contact by December 29, 1999, 5 p.m., E.D.T.
Special Accommodations: Persons attending the meeting who are
hearing or visually impaired and have special requirements, or a
condition that requires special assistance or accommodations, are asked
to notify the Executive Secretary by December 15, 1999.
ADDRESSES: The Meeting: The meeting will be held at the Baltimore
Marriott Inner Harbor, 110 S. Eutaw Street, Baltimore, MD 21201.
Presentations and Comments: Submit formal presentations and written
comments to Constance A. Conrad, Executive Secretary; Office of
Clinical Standards and Quality; Health Care Financing Administration;
7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.
Website: You may access up to date information on this meeting at
www.hcfa.gov/quality/8b.htm.
FOR FURTHER INFORMATION CONTACT: Constance A. Conrad, Executive
Secretary, 410-786-4631.
SUPPLEMENTARY INFORMATION: On August 13, 1999, we published a notice
(64 FR 44231) to describe the MCAC, which provides advice and
recommendations to us about clinical coverage issues. This notice
announces the following public meeting of the MCAC:
Current Panel Members
Alan M. Garber, M.D.; Michael D. Maves, M.D.; Angus M. McBryde,
M.D.; H. Logan Holtgrewe, M.D.; Kenneth P. Brin, M.D.; Les J. Zendle,
M.D.; Bruce Sigsbee, M.D.; Linda D. Bradley, M.D.; James P. Rathmell,
M.D.; Arnold M. Epstein, M.D.; Phyllis E. Greenberger, M.S.W.; Marshall
S. Stanton, M.D.
Meeting Topic
The Panel will hear and discuss presentations from interested
persons regarding behavioral interventions for the management of non-
neurogenic urinary incontinence in adults. The meeting will primarily
focus on two management options: biofeedback and pelvic floor
electrical stimulation.
Procedure and Agenda
This meeting is open to the public. The panel will hear oral
presentations from the public for approximately 2 hours and 30 minutes
on the first day of the meeting. The Panel may limit the number and
duration of oral presentations to the time available. It you wish to
make formal presentations you must notify the For Further Information
Contact, and submit the following by the Deadline for Presentations and
Comments date listed in the Dates section of this notice: a brief
statement of the general nature of the evidence or arguments you wish
to present, the names and addresses of proposed participants, and an
estimate of the time required to make the presentation. We will request
that you declare at the meeting whether or not you have any financial
involvement with manufacturers of any items or services being discussed
(or with their competitors).
After the public presentation, we will make a presentation to the
Panel. After our presentation, the Panel will deliberate openly on the
topic. Interested persons may observe the deliberations, but the Panel
will not hear further comments during this time except at the request
of the chairperson. At the end of the Panel deliberations, the Panel
will allow at least a 30-minute open public session for any attendee to
address issues specific to the topic. After which, the members will
vote and the panel will make its recommendation.
Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare--Supplementary Medical Insurance Program)
Dated: December 7, 1999.
Jeffrey L. Kang,
Director, Office of Clinical Standards and Quality, Health Care
Financing Administration.
[FR Doc. 99-32165 Filed 12-10-99; 8:45 am]
BILLING CODE 4120-01-U
